Finance

Lists
CHM:ASX
Chimeric Therapeutics Ltd
0,0030 A$
0,00%
(0,00) 1D
30 қыр., 17:11:03 GMT+11  ·   AUD
All symbols
SymbolPriceChange% Change
Generating top insights for CHM...
Mkt. cap
177,19 м.
Avg. vol.
2,70 млн
Volume
0,00
52-wk high
0,40 A$
52-wk low
0,00 A$
EPS
-0,61 A$
Shares outstanding
147,46 млн
Mkt. cap
177,19 м.
Avg. vol.
2,70 млн
Volume
0,00
52-wk high
0,40 A$
52-wk low
0,00 A$
EPS
-0,61 A$
Shares outstanding
147,46 млн
News stories
From web sources and news partners
About Chimeric Therapeutics Ltd
CEO-
Employees-
Founded2020
Headquarters-
Sector-
Previous reportsAll values in AUD
Loading Previous Earnings...
Revenue
Net income
All values in AUD
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
1,31 млн
1,31 млн
-1,40 млн
-1,40 млн
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
399,44 м.
399,44 м.
1,31 млн
1,31 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,35 млн
1,35 млн
953,59 м.
953,59 м.
Operating expense
1,94 млн
1,94 млн
2,23 млн
2,23 млн
Total operating expenses
1,94 млн
1,94 млн
2,23 млн
2,23 млн
Operating income
-634,86 м.
-634,86 м.
-3,64 млн
-3,64 млн
Other non operating income
-
-
-8,94 мың
-8,94 мың
EBT including unusual items
-5,59 млн
-5,59 млн
-3,81 млн
-3,81 млн
EBT excluding unusual items
-709,86 м.
-709,86 м.
-3,55 млн
-3,55 млн
Income tax expense
21,60 мың
21,60 мың
-10,53 мың
-10,53 мың
Effective tax rate
-0,39%
-0,39%
0,28%
0,28%
Other operating expenses
-
-
-
-
Net income
-5,61 млн
-5,61 млн
-3,80 млн
-3,80 млн
Net profit margin
-428,19%
-428,19%
270,30%
270,30%
Earnings per share
-
-
-
-
Interest and investment income
13,78 мың
13,78 мың
5,84 мың
5,84 мың
Interest expense
-88,79 мың
-88,79 мың
-55,19 мың
-55,19 мың
Net interest expenses
-75,01 мың
-75,01 мың
-49,35 мың
-49,35 мың
Depreciation and amortization charges
-
-
-
-
EBITDA
-391,47 м.
-391,47 м.
-3,62 млн
-3,62 млн
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google қолданбалары